NCT01257815 Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment Status COMPLETED Phase PHASE4
NCT01255293 Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments Status COMPLETED Phase NA
NCT01223612 Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation Status COMPLETED Phase PHASE4
NCT01220804 Evaluation of Blood-retinal Barrier Functional Alterations by Optical Coherence Tomography Status COMPLETED Phase N/A
NCT01213888 Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy Status TERMINATED Phase NA
NCT01202461 Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) Status COMPLETED Phase PHASE1
NCT01189461 Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT01168258 Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema Status TERMINATED Phase N/A
NCT01131650 Prevalence of Diabetic Retinopathy in São José do Rio Preto-SP-Brazil Status COMPLETED Phase N/A
NCT01102946 Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy Status COMPLETED Phase PHASE2
NCT01075347 Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries Status COMPLETED Phase PHASE1
NCT01023113 To Compare Visual Field Impairment in Conventional Double Frequency Nd: YAG Panretinal Photocoagulation With PASCAL Panretinal Photocoagulation Status UNKNOWN Phase NA